Status:

COMPLETED

Genetic Evaluation of AAAS Gene in Early-Onset Achalasia and Alacrima Patients

Lead Sponsor:

Asan Medical Center

Conditions:

Achalasia

Alacrima

Eligibility:

All Genders

Brief Summary

The AAAS gene has been known to cause achalasia, alacrima, adrenal abnormalities and a progressive neurological syndrome. A considerable proportion of achalasia patients have been known to show alacri...

Eligibility Criteria

Inclusion

  • early age onset
  • primary achalasia patient
  • less than 35 years old

Exclusion

  • secondary achalasia patients

Key Trial Info

Start Date :

April 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2009

Estimated Enrollment :

19 Patients enrolled

Trial Details

Trial ID

NCT00856921

Start Date

April 1 2008

End Date

March 1 2009

Last Update

March 6 2009

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Genetic Evaluation of AAAS Gene in Early-Onset Achalasia and Alacrima Patients | DecenTrialz